thiazoles has been researched along with antipyrine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (56.52) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bragt, PC; Braun, CL; Meuling, WJ | 1 |
| Kitchingman, GA; Langman, MJ; Somerville, KW | 1 |
| Akamatsu, K; Hirabayashi, Y; Kanaoka, M; Masumoto, S; Nakanishi, K; Nishinobu, M; Ohta, Y; Okada, S; Sakaue, H; Sasaki, T | 1 |
| Dicke, JM; Henderson, GI; Johnson, RF; Kuehl, TJ; Schenker, S | 1 |
| Kuroiwa, Y; Misawa, S; Nakamura, K; Tanaka, E | 1 |
| Anderström, C; Johansson, SL | 1 |
| Del Prete, U; Jèzèquel, AM; Orlandi, F; Piersimoni, F | 1 |
| Dammann, HG; DeVries, JX; Koroknay, B; Müller, P; Simon, B; Staiger, C; Weber, E | 1 |
| Dammann, HG; Devries, JX; Korodnay, B; Müller, P; Simon, B; Staiger, C; Weber, E | 1 |
| Anderson, KE; Anziano, RJ; Bauer, LA; Carithens, RL; Everson, G; Johnson, A; Lasseter, KC; Smolarek, TA; Turncliff, RZ; Wilner, KD | 1 |
| Albaladejo, V; Bournique, B; Lerche-Langrand, C; Martin, H; Sarsat, JP | 1 |
| Cook, M; Eckelman, WC; Esaki, T; Itoh, Y; Jagoda, EM; Jehle, J; Kiesewetter, DO; Ravasi, L; Schmidt, K; Shimoji, K; Sokoloff, L | 1 |
| BEYER, H; STEHWIEN, D | 1 |
| MORITA, M | 4 |
| Echizen, H; Oishi, K; Uchida, M; Yamaguchi, T | 1 |
| Baron, O; Ila, H; Knochel, P; Wagner, AJ | 1 |
| Abd el Razik, HA; Ashour, HM; Badr, MH; el-Ashmawy, IM; Rostom, SA | 1 |
| Dai, H; He, P; Hu, Y; Li, W; Ni, Z; Xu, H; Zhang, Z | 1 |
| Fang, W; Geng, X; Han, D; Li, Y; Lv, P; Sha, L; Shang, E; Wei, J; Yang, Q; Zhang, R | 1 |
| Scott, A | 1 |
2 trial(s) available for thiazoles and antipyrine
| Article | Year |
|---|---|
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human].
Topics: Adult; Antipyrine; Cimetidine; Famotidine; Female; Histamine H1 Antagonists; Humans; Kinetics; Male; Thiazoles | 1984 |
The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Antipyrine; Area Under Curve; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Piperazines; Reference Values; Saliva; Thiazoles | 2000 |
21 other study(ies) available for thiazoles and antipyrine
| Article | Year |
|---|---|
Biological monitoring of carbon disulfide.
Topics: Air Pollutants, Occupational; Antipyrine; Carbon Disulfide; Creatinine; Environmental Monitoring; Humans; Thiazoles; Thiazolidines | 1990 |
Effect of famotidine on oxidative drug metabolism.
Topics: Adult; Aminopyrine; Antipyrine; Breath Tests; Famotidine; Half-Life; Histamine H2 Antagonists; Humans; Kinetics; Male; Oxidation-Reduction; Pharmaceutical Preparations; Thiazoles | 1986 |
Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipyrine; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Ranitidine; Thiazoles | 1987 |
A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta.
Topics: Adolescent; Adult; Animals; Antipyrine; Biological Transport; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Nizatidine; Papio; Perfusion; Placenta; Pregnancy; Ranitidine; Thiazoles | 1988 |
The effect of H2-receptor antagonists on antipyrine and pentobarbital metabolism in male and female rats.
Topics: Animals; Antipyrine; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Male; Microsomes, Liver; Mixed Function Oxygenases; Pentobarbital; Ranitidine; Rats; Rats, Inbred Strains; Sex Factors; Thiazoles | 1988 |
The influence of antipyrene on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced urinary tract carcinogenesis.
Topics: Animals; Antipyrine; Cocarcinogenesis; FANFT; Kidney Neoplasms; Kidney Papillary Necrosis; Kidney Pelvis; Male; Rats; Rats, Inbred Strains; Thiazoles; Urinary Bladder Neoplasms | 1988 |
The effect of famotidine, a new H2 receptor antagonist, on antipyrine clearance in healthy volunteers.
Topics: Adult; Antipyrine; Famotidine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Receptors, Histamine H2; Saliva; Thiazoles | 1987 |
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.
Topics: Adult; Antipyrine; Cimetidine; Famotidine; Female; Humans; Kinetics; Male; Thiazoles | 1984 |
Cryopreserved rat liver slices: a critical evaluation of cell viability, histological integrity, and drug-metabolizing enzymes.
Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Antipyrine; Apoptosis; Biotransformation; Cell Survival; Cryopreservation; Cryoprotective Agents; Dimethyl Sulfoxide; Glutathione; Hepatocytes; Insulin; Liver; Male; Organ Culture Techniques; Organ Preservation Solutions; Oxidation-Reduction; Proteins; Raffinose; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles | 2000 |
Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow.
Topics: Animals; Antipyrine; Atropine Derivatives; Binding, Competitive; Blood Pressure; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Fluorine Radioisotopes; Laser-Doppler Flowmetry; Male; Muscarinic Agonists; Pyridines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Thiadiazoles; Thiazoles | 2003 |
[Thiazole. XIV. The preparation of 1-(2'-thiazolyl-)-5-pyrazolone and 4-(4'-thiazolyl-)-antipyrine].
Topics: Analgesics; Antipyrine; Humans; Pyrazolones; Thiazoles | 1953 |
[Synthesis and antibacterial activity of antipyrine derivative. I. 4-Thiazoline-2-thiones, dithiocarbamic acid esters and rhodanines].
Topics: Anti-Bacterial Agents; Antipyrine; Esters; Rhodanine; Thiazoles; Thiazolidines | 1962 |
[Synthesis and antibacterial activity of antipyrine derivatives. IV. Thiazoles. (1)].
Topics: Anti-Bacterial Agents; Antipyrine; Bacteria; Thiazoles | 1962 |
[Synthesis and antibacterial activity of antipyrine derivatives. V. Thiazoles. (2)].
Topics: Anti-Bacterial Agents; Antipyrine; Bacteria; Pregnenes; Thiazoles | 1962 |
[Synthesis and antibacterial activity of antipyrine derivatives. VI. 4-Thiazolidinones].
Topics: Anti-Bacterial Agents; Antipyrine; Thiazoles | 1962 |
Edaravone, a radical scavenger, may enhance or produce antiproliferative effects of fluvastatin, amlodipine, ozagrel, GF109203X and Y27632 on cultured basilar artery smooth muscle cells.
Topics: Amides; Amlodipine; Animals; Antipyrine; Arteriosclerosis; Basilar Artery; Cell Division; Cell Survival; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Edaravone; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Indoles; Maleimides; Methacrylates; Muscle, Smooth, Vascular; Pyridines; Reactive Oxygen Species; Signal Transduction; Tetrazolium Salts; Thiazoles | 2003 |
Functionalized magnesium organometallics as versatile intermediates for the synthesis of polyfunctional heterocycles.
Topics: Antipyrine; Combinatorial Chemistry Techniques; Esters; Furans; Heterocyclic Compounds; Imidazoles; Imines; Iodides; Magnesium; Models, Chemical; Nitriles; Organometallic Compounds; Pyridines; Pyrroles; Quinolines; Thiazoles; Thiophenes; Uracil | 2006 |
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Drug Design; Drug Evaluation, Preclinical; Rats; Structure-Activity Relationship; Thiadiazoles; Thiazoles | 2009 |
Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress.
Topics: Antipyrine; Blotting, Western; Brain; Diabetes Complications; Edaravone; Endothelial Cells; Glycation End Products, Advanced; Humans; Microvessels; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rhodamine 123; Tetrazolium Salts; Thiazoles | 2013 |
Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.
Topics: Animals; Antipyrine; ATP Binding Cassette Transporter, Subfamily B; Blood-Brain Barrier; Blotting, Western; Brain; Brain Edema; Capillaries; Cerebrospinal Fluid; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Coloring Agents; E-Selectin; Edaravone; Endothelial Cells; Evans Blue; Flow Cytometry; Infusions, Intravenous; Male; Matrix Metalloproteinase 9; Microdialysis; Neuroprotective Agents; Platelet Activating Factor; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Serum Albumin, Radio-Iodinated; Tetrazolium Salts; Thiazoles | 2014 |
Drug therapy: On the treatment trail for ALS.
Topics: Amyotrophic Lateral Sclerosis; Antipyrine; Benzamides; C9orf72 Protein; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Edaravone; Genetic Therapy; Humans; Imidazoles; Mesenchymal Stem Cells; Motor Neurons; Neuroglia; Off-Label Use; Oligoribonucleotides, Antisense; Piperidines; Precision Medicine; Pyrazines; Pyridines; Riluzole; RNAi Therapeutics; Stem Cell Transplantation; Superoxide Dismutase; Thiazoles; United States; United States Food and Drug Administration | 2017 |